UnitedHealth Says Fed Suit Imperils Deal's Many Benefits

By Bryan Koenig · February 10, 2025, 6:12 PM EST

UnitedHealth Group and home health and hospice giant Amedisys Inc. responded to the U.S. Department of Justice's merger challenge Friday by telling a Maryland federal judge that the government is taking...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Answer

Case Information

Case Title

United States of America et al v. UnitedHealth Group Incorporated et al

Case Number

Court

Maryland

Nature of Suit

Anti-Trust

Date Filed

November 12, 2024

Recent Articles By Bryan

February 19, 2025
Judge Won't Halt PBM Case Over Attack on FTC Indepenence
February 14, 2025
FTC's Ferguson, PBMs Agree: Nix Leader Removal Safeguards
February 11, 2025
Split 3rd Circ. Keeps Merck Vaccine Antitrust Panel Immunity
January 30, 2025
DOJ Calls UnitedHealth Dismissal Bid A Discovery 'End Run'
January 10, 2025
Infosys Files Antitrust Counterclaims In Trade Secrets Suit
January 09, 2025
Amgen Says Enbrel Protected By Legit Patents, Rulings
January 03, 2025
DOJ Wants Oct. Amedisys Trial, UnitedHealth Wants Aug.
December 19, 2024
FTC Says PBMs Can't Get Preliminary Block In Insulin Case
December 03, 2024
PE-Backed Anesthesia Giant Can't Duck Antitrust Claims
November 15, 2024
PBMs Denied Breakup Of Combined FTC Insulin Price Trial